• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Vertex Pharmaceuticals Incorporated (VRTX)

    -NasdaqGS
    125.12 0.45(0.36%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:125.57
    Open:125.86
    Bid:123.00 x 300
    Ask:126.60 x 100
    1y Target Est:133.00
    Beta:-0.95
    Next Earnings Date:28-Jan-15VRTX Earnings announcement
    Day's Range:124.44 - 126.82
    52wk Range:59.79 - 127.69
    Volume:1,203,862
    Avg Vol (3m):1,521,900
    Market Cap:30.09B
    P/E (ttm):N/A
    EPS (ttm):-2.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for VRTX

    Comparison

    Symbol% ChgMkt Cap
    VRTXDown 0.36%30.09B
    BMY103.61B
    MRK179.09B
    PTCT1.64B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):38.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-3.02
    Quarterly EPS Est (Dec-14) :-0.65
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-2.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback